Aberrant expression of the UPF1 RNA surveillance gene disturbs keratinocyte homeostasis by stabilizing AREG
Roel Bulthuis - Director at NMD Pharma | The Org
NMD Pharma
Monique Schiersing - Director at NMD Pharma | The Org
Aberrant expression of the UPF1 RNA surveillance gene disturbs keratinocyte homeostasis by stabilizing AREG
Argenx køber amerikansk guldkupon til middel, som NMD Pharma skal konkurrere mod
NMD Pharma - Inkef capital
50 Leading Startup Pharmaceutical Companies World Wide -
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis - PharmiWeb.com
Full text] Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: | PGPM
NMD Pharma company information, funding & investors | Dealroom.co